PLx Pharma Inc.
PLXP · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$46,125 | -$15,211 | -$20,502 | $896 |
| Dep. & Amort. | $213 | $416 | $158 | $201 |
| Deferred Tax | $5,493 | $1,662 | $5,723 | $0 |
| Stock-Based Comp. | $2,884 | $1,288 | $876 | $0 |
| Change in WC | $5,414 | -$491 | $871 | $249 |
| Other Non-Cash | $3 | $92 | $215 | -$11,687 |
| Operating Cash Flow | -$32,118 | -$12,244 | -$12,659 | -$9,499 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$102 | -$242 | -$655 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $95 | $0 | $11 | $0 |
| Investing Cash Flow | $95 | -$102 | -$230 | -$655 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $74,484 | $16,820 | $2,104 | $0 |
| Stock Repurch. | $8,035 | $1,737 | $13,751 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $78,966 | $20,793 | $12,640 | $0 |
| Financing Cash Flow | $78,966 | $20,793 | $12,640 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $46,943 | $8,447 | -$249 | -$10,154 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,449 | $14,001 | $14,250 | $24,404 |
| End Cash | $69,392 | $22,449 | $14,001 | $14,250 |
| Free Cash Flow | -$32,118 | -$12,346 | -$12,901 | -$10,154 |